Abstract
The advantages and disadvantages of combination vaccines are set out with a clear indication that, although there are many (described and discussed) influences on in the immunogenicity of a vaccine it would still be of considerable value to be able to deliver such materials with the minimum number of needle-stick injections. Such a situation may become facilitated in the future as vaccines based on plasmid DNA become available; a prospect which is examined in outline in the final section.
Similar content being viewed by others
References
Bloom B.R.: A perspective on issues relating to future vaccines; inCombined Vaccines and Simultaneous Administration: Current Issues and Perspectives (J.C. Williams, K.L. Goldenthal, D.L. Burns, B.P. Lewis Jr., Eds).Ann.New York Acad.Sci. 754, 388–395 (1995).
Dimarchi R., Brooke G., Gale C.: Protection of cattle against foot-and-mouth disease by a synthetic peptide.Science 232, 639 (1986).
Ellis R.: Challenges and development of combination vaccines, pp. 127–132 inNovel Strategies in the Design and Production of Vaccines (A. Cohen, A. Shafferman, Eds). Plenum Press, London 1996.
Halperin S.A., Eastwood B.J., Langley J.M.: Immune responses to pertussis vaccines concurrently administered with viral vaccines; inCombined Vaccines and Simultaneous Administration: Current Issues and Perspectives (J.C. Williams, K.L. Goldenthal, D.L. Burns, B.P. Lewis Jr., Eds).Ann.New York Acad.Sci. 754, 89–96 (1995).
Halsey N.A.: Practical considerations regarding the impact on immunization schedules of the introduction of new combined vaccines; inCombined Vaccines and Simultaneous Administration: Current Issues and Perspectives (J.C. Williams, K.L. Goldenthal, D.L. Burns, B.P. Lewis Jr., Eds).Ann.New York Acad.Sci. 754, 250–254 (1995).
Human Tissue:Ethical and Legal Issues, p. 153. Nuffield Council on Bioethics, London 1995.
Liu M.A., Hilleman M.R., Kurth R. (Eds):DNA Vaccines: A New Era in Vaccinology. New York Acad. Sci., Vol. 772 (1995).
McLintock D.K.: Combination vaccines: regulatory issues; inCombined Vaccines and Simultaneous Administration: Current Issues and Perspectives (J.C. Williams, K.L. Goldenthal, D.L. Burns, B.P. Lewis Jr., Eds).Ann.New York Acad.Sci. 754, 27–34 (1995).
Paradiso P.R.: Combination vaccines for diphtheria, tetanus, pertussis andHœmophilus influenzœ type b; inCombined Vaccines and Simultaneous Administration: Current Issues and Perspectives (J.C. Williams, K.L. Goldenthal, D.L. Burns, B.P. Lewis Jr., Eds).Ann.New York Acad.Sci. 754, 108–113 (1995).
Parkman P.D.:Combined Vaccines and Simultaneous Administration: Current Issues and Perspectives (J.C. Williams, K.L. Goldenthal, D.L. Burns, B.P. Lewis Jr., Eds).Ann.New York Acad.Sci. 754, 1–9 (1995).
Šebo P.: paper presented at aFEMS Internat. Symp. Novel Methods and Standardization in Microbiology, Košice (Slovakia) 1996.
Smith H.: Report in vaccine,in press (1996).
Spier R.E.: Report of a meeting on vaccines; new technologies and applications.Vaccine 13, 1038–1039 (1995).
Spier R.E.: Meeting report for vaccine,in press (1996).
Sutter R.W., Pallansch M.A., Sawyer L.A., Cochi S.L., Hadler S.C.: Defining surrogate serological tests with respect of predicting protective vaccine efficacy: polio vaccination; inCombined Vaccines and Simultaneous Administration: Current Issues and Perspectives (J.C. Williams, K.L. Goldenthal, D.L. Burns, B.P. Lewis Jr., Eds).Ann.New York Acad.Sci. 754, 289–299 (1995).
Wassilak S.G., Glasser J.W., Chen R.T., Hadler S.C. and the vaccine safety data link investigators: Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects; inCombined Vaccines and Simultaneous Administration: Current Issues and Perspectives (J.C. Williams, K.L. Goldenthal, D.L. Burns, B.P. Lewis Jr., Eds).Ann.New York Acad.Sci. 754, 377–382 (1995).
Wolf J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L.: Direct gene transfer into mouse musclein vivo.Science 247, 1465–1468 (1990).
Author information
Authors and Affiliations
Additional information
Given at aFEMS International Symposium on Novel Methods and Standardization in Microbiology, at Košice (Slovakia), July 1–4, 1996.
Rights and permissions
About this article
Cite this article
Spier, R.E. Multivalent vaccines: Prospects and challenges. Folia Microbiol 42, 105–112 (1997). https://doi.org/10.1007/BF02898716
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02898716